About FHH
History
Organizational structure
- Standing Committee
- Sub-Committee
Ex-Chairperson
Members List
Photos
Bulletin Board
Information
Notice
Short Communications
Adulterated Herbal Medicine
- Purpose
- Database
Herbs World Wide
Meetings
Standing Committee
International Symposium
Meeting Materials
Sub-Committee 1
Sub-Committee 2
Sub-Committee 3
FHH Previous Meeting
Projects
Pharmacopoeia
- Purpose
- Products
- Terminology
- Link
FHH Atlas
FHH RMPM
- Purpose
- Results
- Distribution
COVID-19
COVID-19
Link
Link
Sign In
About FHH
History
Organizational structure
Ex-Chairperson
Members List
Photos
History
History
Organizational structure
Ex-Chairperson
Members List
Photos
Meetings
게시물 검색폼
Keyword
ADR
Adulteration
Aflatoxin
Benzopyrene
CITES
Collaboration
DNA
Efficacy
GA(C)P
GMP
Guideline
Heavy metal
Microorganism
Pesticide
Pharmacopoeia
Processing
Quality
Reference substance
Regulation
Registration
Safety
Sulfur dioxide
Surveillance
Training
Year
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
[Total :
709
]
No.
Code
Title
Speaker
Country
268
11th FSC 12 (2013)
Standardization of traditional east asian medicine in ISO TC249
Takashi HAKAMATSUKA
Japan
267
11th FSC 11 (2013).
Comparative studies on JP and Hong Kong chinese materia medica standards
Kawahara NOBUO
Japan
266
11th FSC 10 (2013)
ASEAN traditional medicines & health supplememnts product working group
Li Lim LEE
Singapore
265
11th FSC 09 (2013)
Quality of herbal materials in vietnamese market
NGUYEN Thi Lan Phuong
Vietnam
264
11th FSC 08 (2013)
Development of monographs of materia materica in VP from 2010-2013
NGUYEN Thi Phuong Mai
Vietnam
263
11th FSC 07 (2013)
Overview of complementary health products regulation in Singapore
Tit Keong PANG
Singapore
262
11th FSC 06 (2013)
Recent progress on regulations of herbal medicines in Korea
Rack-Seon SEONG
Republic of Korea
261
11th FSC 05 (2013)
Intro of qNMR to the JP for specification of marker compounds used for standardization of herbal medicines
Yukihiro GODA
Japan
260
11th FSC 04 (2013)
Development of regulatory regime for chinese medicines in Hong Kong
Polly CHAN
Hong Kong SAR, China
46
47
48
49
50
51
52
53
54